Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to -$32.6 million.

  • Select Medical Holdings' Cash from Investing Activities rose 2768.28% to -$32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$223.8 million, marking a year-over-year increase of 115.5%. This contributed to the annual value of -$231.0 million for FY2024, which is 1395.5% up from last year.
  • Latest data reveals that Select Medical Holdings reported Cash from Investing Activities of -$32.6 million as of Q3 2025, which was up 2768.28% from -$64.7 million recorded in Q2 2025.
  • In the past 5 years, Select Medical Holdings' Cash from Investing Activities ranged from a high of -$32.6 million in Q3 2025 and a low of -$99.3 million during Q4 2021
  • In the last 5 years, Select Medical Holdings' Cash from Investing Activities had a median value of -$57.7 million in 2024 and averaged -$59.6 million.
  • Per our database at Business Quant, Select Medical Holdings' Cash from Investing Activities plummeted by 47591.01% in 2021 and then surged by 4234.4% in 2022.
  • Over the past 5 years, Select Medical Holdings' Cash from Investing Activities (Quarter) stood at -$99.3 million in 2021, then surged by 42.34% to -$57.2 million in 2022, then fell by 21.58% to -$69.6 million in 2023, then decreased by 6.62% to -$74.2 million in 2024, then surged by 56.05% to -$32.6 million in 2025.
  • Its Cash from Investing Activities stands at -$32.6 million for Q3 2025, versus -$64.7 million for Q2 2025 and -$52.3 million for Q1 2025.